TMO: שווי שוק לרווח נקי מותאם קצב צמיחה Thermo Scientific

Thermo Fisher Scientific (TMO) is building a biotech ecosystem through active acquisitions, which is reflected in the current PEG ratio on the GURU.Markets website, where the indicator stands at 2.47. Revenues are based on B2B sales of equipment and reagents to clinics, while a global warehouse network ensures supply stability. This chart helps assess the fundamental value of the shares relative to earnings growth rates.

To conduct high-quality asset selection, an investor must correlate a company's market value with its earnings growth. This metric divides the P/E ratio by the expected EPS growth rate, where a value below one signals undervaluation; for Thermo Fisher Scientific (TMO), which possesses pricing power over laboratories, the business undervaluation factor based on PEG allows for the determination of the optimal entry point into a high-margin asset.